GDEX Bhd shares rose after it reportedly entered into a partnership with electronic prescription (e-prescription) provider company, DOC2US and community-based pharmacy, Alpro Pharmacy for safe and real-time traceable drug delivery arrangements.
In a joint statement today, the two firms said that patients who want their medicines delivered home, can track the delivery through a barcode provided by GDEX to make it easier for them to receive the medicines.
GDEX's Chief Operating Officer, Caren Chong, said its staff had undergone in-house training to handle the delivery and manage the storage of medicines.
“Coupled with our barcode tracking system, we are able to ensure that the right medications can be delivered to the right patients and most importantly, in good condition,” Chong said.
Meanwhile, DOC2US Chief Executive Officer (CE0), Dr. Raymond Choy said the strategic collaboration involving Alpro Pharmacy and GDEX would not only improve their processes and productivity but more importantly, provide a good experience in terms of delivering medicines to patients.
"This will also allow us to provide one -stop solutions for patients in terms of digital healthcare, pharmacy supplies to logistics," according to Choy.
Meanwhile, Alpro Pharmacy Group Marketing Director Lee Yin Chen said, unlike other products, medicines need to be handled properly and follow strict guidelines.
"Distributing medicines through delivery while maintaining a high commitment to the safety of medicines can be a challenge," explained Yin Chen.
Add Choy, against more than 300 pharmacies that use electronic delivery/distribution services.
He said that his party aims to work with 1,000 pharmacies this year so that the delivery time of medicines nationwide can be speeded up.
"We will also offer the delivery service of these medicines to all our official pharmacies this year gradually," he said.
At 2.31pm, GDEX shares rose 1.33% or 0.5 sen to 38 sen, bringing its market capitalization to RM2.14 billion.
